论文部分内容阅读
目的探析膀胱部分切除术治疗老年肌层浸润性膀胱癌的可行性及疗效,旨在为今后临床治疗老年肌层浸润性膀胱癌提供参考依据。方法前瞻性选取孟州市中心医院肿瘤内科2013年9月至2015年10月期间收治的100例老年肌层浸润性膀胱癌为研究对象,采用随机数字表法将其分为对照组和实验组,实验组采用膀胱部分切除术,对照组采用经尿道膀胱瘤电切术,并观察两组患者术中和术后各指标以及复发情况。结果实验组手术时间、术中出血量、住院时间及导尿管留置时间等各项指标均明显少于对照组(P<0.05),但生活质量评分明显高于对照组(P<0.05),实验组并发症发生率明显低于对照组(P<0.05),实验组术后第1年无瘤生存率、术后第3年无瘤生存率及复发率均明显低于对照组(P>0.05)。结论膀胱部分切除术治疗老年肌层浸润性膀胱癌,有一定的可行性和安全性,疗效显著,值得临床应用与推广。
Objective To investigate the feasibility and curative effect of partial partial resection of bladder in the treatment of invasive muscle of elderly patients with invasive myasthenia and to provide a reference for clinical treatment of invasive bladder cancer in the elderly. Methods A total of 100 elderly patients with invasive muscle of the muscle in our hospital from September 2013 to October 2015 were prospectively selected from the Department of Oncology, Central Hospital of Mengzhou. The patients were divided into control group and experimental group by random number table , The experimental group was treated with partial resection of the bladder, the control group was treated by transurethral resection of the bladder tumor, and the indexes of the two groups during operation and postoperatively and the recurrence were observed. Results The operation time, intraoperative blood loss, hospital stay and urinary catheter retention time in the experimental group were significantly lower than those in the control group (P <0.05), but the quality of life scores were significantly higher in the experimental group than those in the control group (P <0.05) The incidence of complications in the experimental group was significantly lower than that in the control group (P <0.05). The first-year survival rate of the tumor-free group and the third-year survival rate and recurrence rate of the experimental group were significantly lower than those of the control group (P> 0.05). Conclusion Partial partial resection of the bladder in the treatment of invasive muscle of elderly patients with mycoplasma bladder has a certain feasibility and safety, efficacy is significant, it is worth clinical application and promotion.